| 000 | 00912 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513231104.0 | ||
| 264 | 0 | _c20010208 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1067/mcp.2001.112690 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKessler, K M | |
| 245 | 0 | 0 |
_aDefinition and axioms of net treatment benefit. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cJan 2001 |
||
| 300 |
_a1-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 |
_aTherapeutics _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKessler, D K | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 69 _gno. 1 _gp. 1-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mcp.2001.112690 _zAvailable from publisher's website |
| 999 |
_c11118353 _d11118353 |
||